Massachusetts H5048 mandates a study on health insurance benefits for Ehlers-Danlos syndrome, Alfi’s syndrome, and Factor V Leiden testing.

Massachusetts H5048 directs the House Committee on Financial Services to investigate and study three health insurance mandates: coverage for physical therapy for Ehlers-Danlos syndrome patients, insurance coverage for Alfi’s syndrome, and testing for Factor V Leiden. The committee must report its findings and recommendations, along with any necessary legislative drafts, by December 31, 2026.

Massachusetts H5048 mandates a study on health insurance benefits for Ehlers-Danlos syndrome, Alfi’s syndrome, and Factor V Leiden testing.

Massachusetts H5048 directs the House Committee on Financial Services to investigate and study three health insurance mandates: coverage for physical therapy for Ehlers-Danlos syndrome patients, insurance coverage for Alfi’s syndrome, and testing for Factor V Leiden. The committee must report its findings and recommendations, along with any necessary legislative drafts, by December 31, 2026.